Skip to content
Pomóż nam pomóc większej liczbie osób
  2. Zespół Alporta
  3. Organizacje
  4. Reata Pharmaceuticals - CARDINAL Study for Alport Syndrome

Reata Pharmaceuticals - CARDINAL Study for Alport Syndrome
Reata Pharmaceuticals - CARDINAL Study for Alport Syndrome

Szczegóły

Lokalizacja

Opis

A clinical trial designed specifically for patients with Alport syndrome.

CARDINAL is a Phase 2/3 clinical study evaluating the safety and effectiveness of bardoxolone methyl (an oral investigational drug) for the treatment of Alport syndrome. Up to 210 participants will be enrolled in CARDINAL at approximately 60 research centers around the world.

 

Visit https://www.cardinalclinicaltrial.com/ to learn more.